1-(carboxymethylthio)tetradecane has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aasprong, OG; Berge, RK; Bjørndal, B; Cacabelos, D; Grimstad, T; Hausken, T; Lied, GA; Nylund, K; Omdal, R; Pamplona, R; Portero-Otin, M | 1 |
1 other study(ies) available for 1-(carboxymethylthio)tetradecane and Colitis
| Article | Year |
|---|---|
Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats.
Topics: Animals; Antioxidants; Colitis; Colon; Cytokines; Dextran Sulfate; Dietary Supplements; Gene Expression Regulation; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Sulfides | 2013 |